Comments
FDA approves Amgen's Prolia for new use
21.09.2012. | (Reuters) - Amgen Inc, the world's largest biotechnology company, said U.S. health regulators approved its Prolia injection for a new use as a treatment to increase bone mass in men with osteoporosis at high risk for fracture....
